Recent Finacing
Recent Raise
Aptimmune Biologics develops patented mucosal vaccines for swine (PRRSV, influenza), advancing pipeline development, product registration, and commercialization from its University of Illinois Research Park incubator.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors